,22 Initially used in the CLN1 model to longitudinally investigate deterioration of motor performance and correlating with cerebellar atrophy,8,23 we here apply this technique to measure the clinical outcome effects of fingolimod and teriflunomide treatment longitudinally. Here, PPT1 is linked to Cerebellar atrophy.